You have 9 free searches left this month | for more free features.

hu14.18-IL2

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)

Not yet recruiting
  • Gastrooesophageal Cancer
  • Trastuzumab deruxtecan
  • Southampton, Hampshire, United Kingdom
  • +16 more
Jul 27, 2023

Pretreatment Anti-Therapeutic Antibodies in Patients Treated

Completed
  • Ewing Family of Tumors
  • +3 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 4, 2020

    ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective

    Active, not recruiting
    • Iron-Deficiency Anemia
    • Iron-Deficiency
    • Iron isomaltoside 1000
    • Basel, Switzerland
    • +20 more
    Nov 4, 2022

    Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

    Completed
    • Nalbuphine
    • +2 more
    • Nalbuphine ER
    • Placebo oral tablet
    • Antrim, Northern Ireland, United Kingdom
    • +14 more
    Oct 3, 2022

    MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

    Recruiting
    • Myelodysplastic Syndromes (MDS)
    • Sodium Valproate, Bezafibrate, Medroxyprogesterone
    • Danazol
    • Dudley, England, United Kingdom
    • +7 more
    Aug 12, 2022

    Wounds and Injuries, Venous Leg Ulcer, Infection Trial in United Kingdom (DURAFIBER Ag)

    Completed
    • Wounds and Injuries
    • +2 more
    • DURAFIBER Ag
    • Hull, East Yorkshire, United Kingdom
    • +6 more
    Feb 28, 2022

    Melanoma Stage IIIB/C Trial in Spain, Switzerland, United States (Daromun, Surgery, Adjuvant therapy)

    Recruiting
    • Melanoma Stage IIIB/C
    • La Jolla, California
    • +30 more
    Dec 22, 2022

    Solid Tumors Trial in Japan (E7389-LF, Nivolumab)

    Active, not recruiting
    • Solid Neoplasms
    • Nagoya, Aichi, Japan
    • +18 more
    Jan 31, 2023

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

    Recruiting
    • Previously Untreated Acute Myeloid Leukemia
    • Samalizumab (BAML-16-001-S1)
    • +32 more
    • Phoenix, Arizona
    • +18 more
    Oct 17, 2022

    IgA Nephropathy Trial in United States (Telitacicept 160mg, Telitacicept 240mg, Placebo)

    Recruiting
    • IgA Nephropathy
    • Telitacicept 160mg
    • +2 more
    • Los Angeles, California
    • +15 more
    Feb 7, 2022

    Plaque Psoriasis Trial in Italy, Spain (Tildrakizumab 100 mg Solution for Injection)

    Completed
    • Plaque Psoriasis
    • Tildrakizumab 100 mg Solution for Injection
    • Ancona, Italy
    • +38 more
    Feb 9, 2022

    Atopic Dermatitis Trial in Worldwide (MEDI3506, Placebo)

    Completed
    • Atopic Dermatitis
    • Birmingham, Alabama
    • +41 more
    Oct 11, 2022

    Neuroblastoma Trial in Vienna, Berlin, Genova (ch14.18/CHO)

    Completed
    • Neuroblastoma
    • Vienna, Austria
    • +2 more
    Oct 21, 2020

    Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)

    Recruiting
    • Atopic Dermatitis
    • Lebrikizumab
    • Darmstadt, Hessen, Germany
    • +31 more
    Jun 21, 2023

    Oropharyngeal Cancer Trial in United Kingdom (Cisplatin, Durvalumab, Radiotherapy)

    Recruiting
    • Oropharyngeal Cancer
    • Exeter, Devon, United Kingdom
    • +32 more
    Nov 29, 2021

    Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Brasschaat, Belgium
    • +53 more
    Nov 29, 2022

    Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)

    Active, not recruiting
    • Head and Neck Cancer
    • recombinant thyroid-stimulating hormone
    • Radiodine ablation without rhTSH
    • Brighton, England, United Kingdom
    • +24 more
    Oct 13, 2021

    COVID-19, Influenza Trial in Quzhou (Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose

    Completed
    • COVID-19
    • Influenza
    • Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.
    • Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.
    • Quzhou, Zhejiang, China
      Kaihua county Center for Disease Control and Prevention
    Jul 23, 2021

    Melanoma Trial in Groningen (IL2-PET scan, Tumor biopsy, CT scan)

    Terminated
    • Melanoma
    • IL2-PET scan
    • +3 more
    • Groningen, Netherlands
      University Medical Center Groningen
    Mar 19, 2020

    Moderate to Severe Plaque Psoriasis Trial in El Salvador, United States (Placebo, SCD-044_Dose 1, SCD-044_Dose 2)

    Recruiting
    • Moderate to Severe Plaque Psoriasis
    • Placebo
    • +3 more
    • Yuma, Arizona
    • +19 more
    Aug 26, 2022

    Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)

    Active, not recruiting
    • Generalized Myasthenia Gravis
    • efgartigimod PH20 SC
    • Carlsbad, California
    • +46 more
    Jul 5, 2022

    Presbyopia Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Placebo)

    Completed
    • Presbyopia
    • Phentolamine Ophthalmic Solution 0.75%
    • +2 more
    • Laguna Hills, California
    • +16 more
    Jun 20, 2022

    Glioma Glioblastoma Multiforme Trial in United Kingdom (Standard of Care, Additional pre- and intra-operative imaging)

    Recruiting
    • Glioma Glioblastoma Multiforme
    • Standard of Care
    • Additional pre- and intra-operative imaging
    • Birmingham, United Kingdom
    • +23 more
    May 26, 2022

    NSCLC Trial in Worldwide (Nivolumab)

    Completed
    • Non-Small Cell Lung Cancer
    • Wels, Oberösterreich, Austria
    • +89 more
    Oct 17, 2022